D & M Pharma operates within a growing Peruvian pharmaceutical market, which was valued at approximately $1.35 billion in 2025. The company’s operations are subject to the technical regulations of DIGEMID , the Peruvian national authority for medicines and medical devices. D & M Pharma Peru S.A.C. Company Profile - EMIS
To maintain its position in the pharmaceutical industry, D&M Pharma Peru adheres to strict local and international standards: d amp m pharma peru sac